Spravato ® (Esketamine) Treatment
Spravato®, a derivative of esketamine, creates a transformative journey for the mind. As a breakthrough medicine, it can rapidly reduce the symptoms of anxiety and depression, offering new possibilities for mental well-being.
What is Esketamine?
Esketamine has clinically proven to be successful in reducing the symptoms of treatment-resistant depression. Derived from ketamine, a well-known anesthetic, esketamine is administered as a nasal spray and acts quickly, providing rapid relief for anxiety and depression.
Esketamine immediately impacts brain cells, providing relief from symptoms of depression within hours. Esketamine is especially effective at reducing suicidal thoughts.
Esketamine increases levels of glutamate and dopamine, two key chemical messengers, within the brain. Increased signaling improves brain cell communication, creating a more dynamic network.
Form New Connections
Esketamine helps repair neurons damaged by chronic depression, restoring and enhancing new neuron connections.
Our Providers are Experts in Spravato® (Esketamine) Treatment
Trusted counselors, 5-star results
“My counselor was very understanding and very helpful for me to understand about the issues worries fears that I was dealing with it’s the first one I already feel like I’m on the right path to a better life.”
“My first experience was so great, it was easy to log on and I got a lot of reminders before the appointment! The person I met with is so welcoming and I felt at ease, so grateful to continue my healing journey!!”
“I had a great session meeting with the practitioner and we scheduled a few more sessions so I look forward to speaking with them again. Excellent job all around. Thank you!”
Frequently Asked Questions
What is Spravato/Nasal Esketamine?
Esketamine (Spravato) is derived from ketamine, a well-known anesthetic, and is administered as a nasal spray that acts quickly, providing rapid relief for anxiety and depression. Sparvato is the brand name for esketamine.
Am I a good candidate for Esketamine?
Determining whether you are a suitable candidate for Esketamine (Spravato) involves a thorough evaluation by a qualified Headlight clinician. Esketamine is prescribed for individuals with treatment-resistant depression or Major Depressive Disorder that has not responded to other treatments. Factors such as medical history, current medications, and overall health will be considered.
What should I expect while using Spravato?
While using Esketamine (Spravato), you can expect to receive the medication in one of Headlight’s offices, administered as a nasal spray. After administration, you may experience dissociation, dizziness, or sedation, so it’s important to have someone available to drive you home. Your clinician will provide guidance and monitor your response during and after each session. It is important to discuss any concerns or questions with your provider for a personalized understanding of what to expect during your Spravato treatment.
Are there side effects?
Common side effects may include dissociation, dizziness, nausea, and increased blood pressure. It’s crucial to discuss potential side effects and your medical history with your clinician for personalized information and guidance.
Is it FDA approved?
Yes, Spravato (esketamine), is approved by the U.S. Food and Drug Administration (FDA) for the treatment of treatment-resistant depression and Major Depressive Disorder.
More than 50% of Americans struggle with mental health.
Headlight is now collaborating with health plans and companies to make therapy more accessible and affordable. Speak to a Care Coordinator today.